Status:

COMPLETED

Navigator Guided e-Psychoeducational Intervention

Lead Sponsor:

H. Lee Moffitt Cancer Center and Research Institute

Collaborating Sponsors:

Patient-Centered Outcomes Research Institute

Conditions:

Prostate Cancer

Eligibility:

MALE

40-80 years

Brief Summary

The purpose of this study is to evaluate the impact of providing newly diagnosed prostate cancer patients and their caregivers with an interactive mobile tablet technology-based application delivered ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Men newly diagnosed (within 6 months) with biopsy confirmed case of prostate cancer
  • 40 - 80 years of age
  • Able to speak and read English
  • Live within 120 miles of a healthcare treatment facility
  • Have no documented or observable visual, auditory, psychiatric, or neurological disorders that would interfere with study participation
  • Be able to complete telephone interviews
  • Have not completed the first course of treatment
  • Have a family member/caregiver willing to participate
  • Capable of providing written consent for study participation. Men diagnosed with early stage, locally advanced or metastatic disease or men who are on active surveillance will be eligible to participate in this study.
  • Caregiver must be aged 18 or older
  • Caregiver must be identified by patient as their caregiver (i.e., provider of emotional and/or physical care)
  • Caregiver must have not been diagnosed with cancer in the previous year or be receiving cancer treatment

Exclusion

    Key Trial Info

    Start Date :

    June 2 2014

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    August 17 2017

    Estimated Enrollment :

    391 Patients enrolled

    Trial Details

    Trial ID

    NCT02186444

    Start Date

    June 2 2014

    End Date

    August 17 2017

    Last Update

    August 22 2017

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    H. Lee Moffitt Cancer and Research Institute

    Tampa, Florida, United States, 33612